Management of diabetic foot ulcers: dermatology perspective

Authors

  • Adi Agung Anantawijaya Daryago Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Fitriani Fitriani Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Soenarto Kartowigno Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Inda Astri Aryani Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Yulia Farida Yahya Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Sarah Diba Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Aurelia Stephanie Department of Dermatology and Venereology Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Denpasar, Indonesia

DOI:

https://doi.org/10.15562/bdv.v4i2.65

Keywords:

Diabetes mellitus, diabetic foot ulcers, management.

Abstract

Diabetes mellitus (DM) is a chronic and complex disease that affects various parts of the body. It can lead to multiple systemic complications and also cutaneous manifestation. Diabetic foot ulcer (DFU) is one of the most devastating complications of DM in dermatology. The main etiology is an increase in plasma glucose, risk factors, or comorbidities due to DM itself. Neglected DFU can lead to further complications, including high amputation and mortality rates; thus, the healing of ulcers is the main objective of the treatment. Management is divided into the standard of care and adjuvant therapies. This study aims to optimize DFU management, so it can provide proper treatment and prevent complications.

Author Biographies

Adi Agung Anantawijaya Daryago, Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang,
Indonesia

Fitriani Fitriani, Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang,
Indonesia

Soenarto Kartowigno, Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang,
Indonesia

Inda Astri Aryani, Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang,
Indonesia

Yulia Farida Yahya, Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang,
Indonesia

Sarah Diba, Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang,
Indonesia

Aurelia Stephanie, Department of Dermatology and Venereology Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Denpasar, Indonesia

Department of Dermatology and Venereology Faculty of Medicine, Universitas Udayana/Sanglah General Hospital, Denpasar, Indonesia

References

Schachtel A, Kalus A. Diabetes and other endocrine diseases. In: Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, et al, editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill Education, 2019. p. 2493-526.

Kementrian kesehatan RI. Laporan hasil riset kesehatan dasar [internet]. Jakarta: Badan penelitian dan pengembangan kesehatan kementerian kesehatan RI, 2018. Cited 2021 May 18. Available from: https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasar-riskesdas/.

Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1:e3280.

Sinulingga S, Kohar E, Subandrate. Hubungan profil lipid dengan kejadian ulkus kaki diabetik pada pasien diabetes melitus tipe 2 RSUP dr. Mohammad Hoesin Palembang. SJM. 2018;1(3):183-92.

Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):1–10.

Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018;1411(1):153–65.

Ramirez-Acuña JM, Cardenas-Cadena SA, Marquez-Salas PA, Garza-Veloz I, Perez-Favila A, Cid-Baez MA, et al. Diabetic foot ulcers: Current advances in antimicrobial therapies and emerging treatments. Antibiotics (Basel). 2019;8(4):193.

Noor S, Zubair M, Ahmad J. Diabetic foot ulcer - A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr Clin Res Rev. 2015;9(3):192–9.

Turan Y. Does physical therapy and rehabilitation improve outcomes for diabetic foot ulcers? World J Exp Med. 2015;5(2):130–9.

Bandyk DF. The diabetic foot: Pathophysiology, evaluation, and treatment. Semin Vasc Surg [Internet]. 2018;31(2–4):43–8.

Lane KL, Abusamaan MS, Voss BF, Thurber EG, Al-hajri N, Gopakumar S, et al. HHS Public Access. 2021;34(10).

Boulton AJM, Armstrong DG, Kirsner RS, Attinger CE, Lavery LA, Lipsky BA, et al. Diagnosis and management of diabetic foot complications. Arlington (VA): American Diabetes Association; 2018.

Faraz A, Ashraf H, Khalid S, Fatima R. Foot pressure abnormalities, radiographic, and Charcot changes in the diabetic foot. In: Zubair M, Ahmad J, Malik A, Talluri MR, editors. Diabetic foot ulcer: an update. 1st ed. Singapore: Springer Nature, 2021. p. 121-34.

Bus SA. The role of pressure offloading on diabetic foot ulcer healing and prevention of recurrence. Plast Reconstr Surg. 2016;138(3 Suppl):179S-187S.

Merheb M, Gharios E, Younes A, Cheikh M Al, Chaaban T. Effect of total contact cast in non-healing diabetic foot ulcers in Lebanese patients. Int Wound J. 2017;14(5):751–3.

Sudhir S, Dilip DK, Thiagarajan K, Naik D, Vasudevaiah T. Efficacy of total contact cast application versus conventional dressings in the management of plantar diabetic ulcers. Int J Surg Sci. 2020;4(4):70-2.

Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, et al. Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol [Internet]. 2014;70(1):e1-24.

Mavrogenis AF, Megaloikonomos PD, Antoniadou T, Igoumenou VG, Panagopoulos GN, Dimopoulos L, et al. Current concepts for the evaluation and management of diabetic foot ulcers. EFORT Open Rev. 2018;3(9):513–25.

Saco M, Howe N, Nathoo R, Cherpelis B. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Dermatol Online J. 2016;22(8):13030.

Motley TA, Caporusso JM, Lange DL, Eichelkraut RA, Cargill DI, Dickerson JE. Clinical Outcomes for Diabetic Foot Ulcers Treated with Clostridial Collagenase Ointment or with a Product Containing Silver. Adv Wound Care. 2018;7(10):339–48.

Riley KN, Herman IM. Collagenase promotes the cellular responses to injury and wound healing in vivo. J Burns Wounds. 2005;4:e8.

Pinheiro MARQ, Ferraz JB, Junior MAA, Moura AD, da Costa MESM, Costa FJMD, et al. Use of maggot therapy for treating a diabetic foot ulcer colonized by multidrug resistant bacteria in Brazil. Indian J Med Res Suppl. 2015;141(3):340–2.

Malekian A, Esmaeeli Djavid G, Akbarzadeh K, Soltandallal M, Rassi Y, Rafinejad J, et al. Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers: A Randomized Controlled Trial. J Wound Ostomy Cont Nurs. 2019;46(1):25–9.

Tsang KK, Kwong EWY, To TSS, Chung JWY, Wong TKS. A Pilot Randomized, Controlled Study of Nanocrystalline Silver, Manuka Honey, and Conventional Dressing in Healing Diabetic Foot Ulcer. Evid Based Complement Alternat Med. 2017;2017:5294890.

Xu J, Min D, Guo G, Liao X, Fu Z. Experimental study of epidermal growth factor and acidic fibroblast growth factor in the treatment of diabetic foot wounds. Exp Ther Med. 2018;15(6):5365–70.

Shao S, Pan R, Chen Y. Autologous Platelet-Rich Plasma for Diabetic Foot Ulcer. Trends Endocrinol Metab [Internet]. 2020;31(12):885–90.

Babaei V, Afradi H, Gohardani HZ, Nasseri F, Azarafza M, Teimourian S. Management of chronic diabetic foot ulcers using platelet-rich plasma. J Wound Care. 2017;26(12):784–7.

Hirase T, Ruff E, Surani S, Ratnani I. Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review. World J Diabetes. 2018;9(10):172–9.

Haimovic A, Sheehan JM, Rohrer TE. Excisional surgery and repair, flaps, and grafts. In: Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, et al, editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill Education, 2019. p. 3726-60.

Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics. Int Wound J. 2019;16(1):19–29.

Hunt SD, Elg F. Clinical effectiveness of hemoglobin spray (granulox†) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabet Foot Ankle. 2016;7:33101.

Chen CY, Wu RW, Hsu MC, Hsieh CJ, Chou MC. Adjunctive hyperbaric oxygen therapy for healing of chronic diabetic foot ulcers: A randomized controlled trial. J Wound Ostomy Cont Nurs. 2017;44(6):536–45.

Meloni M, Izzo V, Vainieri E, Giurato L, Ruotolo V, Uccioli L. Management of negative pressure wound therapy in the treatment of diabetic foot ulcers. World J Orthop. 2015;6(4):387–93.

Aldana PC, Khachemoune A. Diabetic foot ulcers: appraising standard of care and reviewing new trends in management. Am J Clin Dermatol. 2020;21(2):255-64.

Downloads

Published

2021-12-30

Issue

Section

Articles